#BLSM

BlossomHill Therapeutics Shares Rally 4.4% on Positive Lung Cancer Trial Data

BlossomHill Therapeutics stock gains 4.4% as the company reports a 45% objective response rate for its BH-30643 lung cancer treatment in the…